7 citations
,
March 2015 in “British Journal of Dermatology” Applying minoxidil can help improve hair growth in people with hair loss caused by LIPH gene mutations.
5 citations
,
October 1993 in “International Journal of Dermatology” This study found that 2% minoxidil led to moderate to dense hair growth in 80% of Middle-Eastern men treated for 48 weeks with early androgenic alopecia.
4 citations
,
December 2023 in “Research Review” In this retrospective cohort study, researchers reported that 77% of 300 COVID-19 survivors experienced long COVID-19 symptoms such as fatigue and hair loss, with symptoms more likely in females, younger age groups, and hospitalized patients.
4 citations
,
January 2016 in “Journal of cosmetology & trichology” This study reports a case where hair loss over the temporal region was associated with prolonged mobile phone use, and suggests that a combination of minoxidil, nutritional therapy, and reduced phone exposure may aid regrowth.
3 citations
,
May 2016 in “International Journal of Research in Ayurveda and Pharmacy” This paper reviews the potential of Ayurvedic herbs like ginger, garlic, and turmeric to reduce the side effects of cancer therapies and enhance patient wellbeing but reports no new experimental findings.
2 citations
,
July 2022 in “Cureus” This case report describes a rare patient with Sjogren's syndrome who experienced recurrent pneumothorax, resolved through surgical intervention, highlighting pneumothorax as an unusual complication of the condition.
2 citations
,
February 2022 in “Research Square (Research Square)” This study found that the ethanolic root extract of Onosma dichroantha exhibits antioxidant activity and significant antimicrobial effects against 11 bacterial species.
2 citations
,
March 2021 in “Carpathian Journal of Food Science and Technology” This review discusses the medicinal and health benefits of caraway, Chinese chives, and cassia, focusing on their antibacterial, antioxidant, antimicrobial, anti-inflammatory, and anticancer properties due to their range of secondary metabolites.
1 citations
,
January 2024 in “Journal of Community Medicine & Public Health” In this study, researchers observed that low-risk COVID-19 hospital staff experienced similar persistent symptoms for at least 30 days after discharge, suggesting the need for targeted monitoring and parameter indicators post-infection clearance.
1 citations
,
January 2024 in “American journal of clinical and experimental immunology.” This study reports that cutaneous manifestations such as herpes zoster, purpura, and livedo reticularis in COVID-19 patients can potentially indicate disease severity, aiding in the prediction of the illness's progression and guiding dermatological management during the pandemic.
1 citations
,
July 2022 in “Case reports in endocrinology” This case report concludes that a combination of physical examination, hormonal evaluation, and imaging studies is crucial for identifying malignant adrenal masses, with radical excision and adjuvant therapy improving patient outcomes.
1 citations
,
March 2022 in “Anaesthesia Pain & Intensive Care” In this study, 60.7% of faculty and their family members at Fazaia Ruth Pfau Medical College in Karachi experienced post-COVID symptoms, with no clear link to COVID infection severity.
1 citations
,
April 2018 in “Lasers in Surgery and Medicine” This review summarizes late-breaking abstracts from the American Society for Laser Medicine and Surgery, 2018, and reports no new clinical findings.
1 citations
,
February 2018 in “Orthopedics and rheumatology” This study found that combining intra-arterial chemotherapy with Traditional Chinese Medicine may improve response rates in malignant bone and soft tissue tumor treatment while also managing specific side effects.
January 2026 in “International Journal of Unani and Integrative Medicine” This review correlates modern biomedical and Unani medical perspectives on PCOS, suggesting that integrating both approaches might improve symptom management and quality of life for affected women, though it reports no new clinical results.
August 2025 in “International Journal of Research in Dermatology” This study found that adding cyclophosphamide to glucocorticoid treatment for pemphigus patients led to earlier remission, with 89.5% achieving remission within 4 months compared to 73.9% with glucocorticoids alone, suggesting significant steroid-sparing effects and improved clinical outcomes.
December 2024 in “THE SCIENTIFIC TEMPER” In this study, women's health in Raichur district slums was found to be significantly impacted by hypertension, malaria, joint pain, and other ailments aggravated by poor sanitation and poverty.
December 2023 in “Health economics and management review” In this descriptive research conducted in Tirunelveli City, Tamil Nadu, the study identified common health problems among radiographers, including tiredness, body pain, and emotional disturbances, highlighting the need to address these issues to ensure accurate disease diagnosis and treatment in healthcare settings.
December 2023 in “Tuberkuloz ve Toraks/Tüberküloz ve toraks” This study identified female sex and specific radiological findings as risk factors for chronic post-COVID syndrome, while long-term use of angiotensin-2 receptor blockers was linked to fewer chronic symptoms.
January 2023 in “Indian Journal of Unani Medicine” This review discusses the chemical composition, pharmacological properties, and ethnomedical applications of Myrtus communis Linn and reports no new clinical results.
April 2022 in “Research Square (Research Square)” This study found that long COVID symptoms vary over time, with pulmonary symptoms improving the most, while hair loss showed the poorest treatment outcomes and several factors like smoking slowed recovery.
March 2022 in “Research Square (Research Square)” This case report describes a 15-year-old girl with Alopecia Universalis and psychiatric conditions experiencing hair regrowth after self-medicating with cannabis, suggesting it may have therapeutic potential.
This study found that both oral minoxidil and topical 5% minoxidil were effective and safe for treating female pattern hair loss over 24 weeks, with oral administration not being inferior to topical treatment.
February 2021 in “Journal of nursing education and practice” This study found that while kidney transplant recipients generally reported good quality of life on immunosuppressive therapies, women experienced more distressing symptoms and lower satisfaction compared to men.
January 2020 in “Indian Journal of Pharmaceutical Sciences” In this study, combining Kuntai capsules with nilestriol tablets for three months was found to reduce symptoms of perimenopausal syndrome and improve reproductive hormone levels more effectively than nilestriol alone; however, the benefits did not persist significantly beyond three months.
May 2019 in “Pakistan Journal of Pharmaceutical Sciences” This case report presented a female with PCOS treated with metformin who developed hyperuricemia, migraine, neurological and joint pain, and rheumatic fever, later showing a delayed hypersensitivity reaction to benzathine benzyl penicillin treatment.
This chapter classifies various benign skin tumors and discusses their characteristics, treatment indications, and potential for recurrence, but reports no new clinical findings.
January 2011 in “Healthcare Informatics Research” This study found that symptoms like dry hair, seborrheic scalps, and certain lifestyle factors correlate with hair loss in patients at hair loss clinics.
January 2009 in “Side effects of drugs annual” This chapter reviews drugs affecting blood coagulation and details the increased hemorrhage risk associated with warfarin interactions, liver disease, heart failure, and antiphospholipid antibodies but reports no new clinical results.
January 2009 in “Side effects of drugs annual” This study observed no teratogenic effects of oral decongestants and surprisingly favorable neonatal outcomes in Swedish women who used them during pregnancy.